The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...

The phosphoinositide 3-kinase (PI3K) pathway is a crucial signal ... Inhibitors that target key components of this pathway, including PI3K, AKT and mammalian target of rapamycin (mTOR), are ...

Blaustein and colleagues concluded that activation of the PI 3-kinase signaling pathway by Ras(V12-C40) in turn activated AKT kinase, resulting in a change in the fibronectin splicing pattern to ...

Despite significant advances in Parkinson's disease (PD) treatment, it remains incurable, with limited therapeutic options.